Conmed Corp CNMD
News
-
CONMED Corporation Announces Preliminary Third Quarter Financial Information
-
CONMED Corporation to Participate in a Virtual Fireside Chat at the CL King Best Ideas Conference
-
CONMED Corporation to Participate in a Fireside Chat at the Wells Fargo Healthcare Conference
-
CONMED Corporation Announces Quarterly Cash Dividend
-
CONMED Corporation Announces Second Quarter 2024 Financial Results
-
CONMED Corporation to Announce Second Quarter 2024 Financial Results on July 31, 2024
Trading Information
- Previous Close Price
- $66.56
- Day Range
- $65.97–69.81
- 52-Week Range
- $61.05–117.27
- Bid/Ask
- $64.68 / $80.58
- Market Cap
- $2.05 Bil
- Volume/Avg
- 461,560 / 425,913
Key Statistics
- Price/Earnings (Normalized)
- 17.85
- Price/Sales
- 1.64
- Dividend Yield (Trailing)
- 1.20%
- Dividend Yield (Forward)
- 1.20%
- Total Yield
- 1.20%
Company Profile
Conmed Corp is a Utica, New York-based medical equipment company that focuses on sports medicine procedures and general surgeries. The firm currently reports through two reporting units, orthopedic surgery, and general surgery. From a geographic perspective, the firm is U.S.-centric, with maximum domestic sales accounting for revenue, EMEA accounting for second place, APAC at third, and the non-U.S. Americas region driving the remaining revenue.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Core
- Total Number of Employees
- 4,000
- Website
- https://www.conmed.com
Comparables
Valuation
|
Metric
|
CNMD
|
688016
|
002901
|
|---|---|---|---|
Price/Earnings (Normalized) | 17.85 | 22.39 | 907.94 |
Price/Book Value | 2.33 | 3.46 | 4.23 |
Price/Sales | 1.64 | 9.68 | 7.61 |
Price/Cash Flow | 11.33 | 19.38 | 35.09 |
Price/Earnings
CNMD
688016
002901
Financial Strength
|
Metric
|
CNMD
|
688016
|
002901
|
|---|---|---|---|
Quick Ratio | 1.01 | 8.91 | 1.68 |
Current Ratio | 2.34 | 9.53 | 2.95 |
Interest Coverage | 4.20 | 413.50 | 13.19 |
Quick Ratio
CNMD
688016
002901
Profitability
|
Metric
|
CNMD
|
688016
|
002901
|
|---|---|---|---|
Return on Assets (Normalized) | 5.07% | 16.12% | 1.51% |
Return on Equity (Normalized) | 14.10% | 18.19% | 2.20% |
Return on Invested Capital (Normalized) | 8.09% | 17.54% | 1.37% |
Return on Assets
CNMD
688016
002901
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| Bxsyckfkb | Ggprwc | $196.0 Bil | |||
| Stryker Corp
SYK
| Ysfcqyynq | Lpmm | $133.8 Bil | |||
| Boston Scientific Corp
BSX
| Fnrqkbmrw | Lcsjrh | $124.5 Bil | |||
| Medtronic PLC
MDT
| Jtgllnsl | Lyvflsq | $113.2 Bil | |||
| Edwards Lifesciences Corp
EW
| Xmwgfgck | Vhpxb | $39.5 Bil | |||
| Koninklijke Philips NV ADR
PHG
| Hqtc | Hmjh | $30.2 Bil | |||
| DexCom Inc
DXCM
| Cbhngksqw | Rhjmd | $27.3 Bil | |||
| Steris PLC
STE
| Hdymnmpys | Zjyfvj | $22.8 Bil | |||
| Zimmer Biomet Holdings Inc
ZBH
| Zcnllnfmj | Ckjn | $21.3 Bil | |||
| Insulet Corp
PODD
| Ndxbrpwnb | Qhmzdgz | $16.1 Bil |
United States